232 results on '"Cieri, Nicoletta"'
Search Results
2. Enhancing CAR-T cell functionality in a patient-specific manner
3. Mechanisms of response and resistance to combined decitabine and ipilimumab for advanced myeloid disease
4. Landscape of helper and regulatory antitumour CD4+ T cells in melanoma
5. Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
6. Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
7. Mapping the evolution of T cell states during response and resistance to adoptive cellular therapy
8. NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: dynamics and clinical implications
9. Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas
10. PD-L1, LAG3, and HLA-DR are increasingly expressed during smoldering myeloma progression
11. NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease
12. Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP
13. Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic GvHD and Candidate Gvl Targets
14. Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT
15. Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells
16. Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation
17. Mechanisms of Response and Resistance to Combination Decitabine and Ipilimumab for Transplant Naïve and Post-Transplant AML/MDS
18. Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic Gvhd and Candidate GVL Targets
19. Single-cell analysis reveals immune dysfunction from the earliest stages of CLL that can be reversed by ibrutinib
20. IL-7 and IL-15 instruct the generation of human memory stem T cells from naive precursors
21. Mitochondrial DNA Mutations Distinguish Individual Donor- and Recipient-Derived Immune Cells Following Matched Unrelated Allogeneic Stem Cell Transplantation
22. 655 Landscape of helper and regulatory CD4+ T cells in melanoma
23. 60 Years Young: The Evolving Role of Allogeneic Hematopoietic Stem Cell Transplantation in Cancer Immunotherapy
24. Splice it up: Atypical transcripts to boost leukemia immunotherapy
25. Adoptive immunotherapy with genetically modified lymphocytes in allogeneic stem cell transplantation
26. Landscape of helper and regulatory antitumour CD4+ T cells in melanoma.
27. Molecular and cellular features of CTLA-4 blockade for relapsed myeloid malignancies after transplantation
28. Local and Systemic Effects of Immune Checkpoint Blockade on Relapsed Myeloid Malignancies Following Allogeneic Hematopoietic Stem Cell Transplantation
29. 35 - Systematic Identification of Autosomal and Y-Encoded Minor Histocompatibility Antigens Reveals Predictors of Chronic GvHD and Candidate Gvl Targets
30. CD4+ Memory Stem T Cells Recognizing Citrullinated Epitopes Are Expanded in Patients With Rheumatoid Arthritis and Sensitive to Tumor Necrosis Factor Blockade
31. Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma.
32. Landscape of helper and regulatory antitumour CD4+T cells in melanoma
33. Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation
34. Real-life feasibility of salvage allogeneic transplantation in peripheral T-cell lymphomas
35. Exhausted Central Memory and Memory Stem T Cells Specific for Leukemia Infiltrate the Bone Marrow of AML Patients Relapsing after Allogeneic HSCT
36. Phenotype, specificity and avidity of antitumour CD8+T cells in melanoma
37. In vivo tracking of T cells in humans unveils decade-long survival and activity of genetically modified T memory stem cells
38. CD3+ Graft Cell Count Predicts Chronic Gvhd Incidence in Haploidentical Allogeneic Transplantation Using Post-Transplant Cyclophosphamide
39. Natural Killer Cell Reconstitution after Haploidentical Hematopoietic Stem Cell Transplantation with Post-Transplant Cyclophosphamide: Elimination of Donor-Derived Mature Alloreactive NK Cells, but Favorable Conditions for Adoptive Immunotherapy
40. How to Monitor Immune Reconstitution Following Allogeneic Hematopoietic Stem Cell Transplantation: A Survey from the EBMT- Cellular Therapy & Immunobiology Working Party
41. Role of Cell Source and Graft Composition in Haploidentical Transplantation Using Post-Transplant Cyclophosphamide
42. Multiple Inhibitory Receptors Are Expressed on Central Memory and Memory Stem T Cells Infiltrating the Bone Marrow of AML Patients Relapsing after Allo-HSCT
43. Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing
44. An Analytic Framework for the Prediction of Gvl Minor Histocompatibility Antigens to Prevent or Treat Post-Transplant Relapse
45. Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation
46. Integrative Single-Cell Tracking of Clonal Evolution, Leukemia Phenotypes and Donor Engraftment Following Allogeneic Stem Cell Transplant Using Mitochondrial DNA Mutations
47. 752. Single Chain TCR Gene Editing in Adoptive Cell Therapy for Multiple Myeloma
48. Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory
49. Low-Dose Antithymocyte Globulin, Post-Transplant Cyclophosphamide and Sirolimus As Graft-Versus-Host Disease Prophylaxis in Unrelated Donor Transplants
50. Rituximab for indolent lymphomas before and after allogeneic hematopoietic stem cell transplantation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.